E2A expression stimulates Ig hypermutation

Journal of Immunology

Volumn 177, Issue 1, 2006, Pages 395-400

  Schoetz, Ulrike ^a   Cervelli, Manuela ^a,b   Wang, Yan Dong ^a   Fiedler, Petra ^a   Buerstedde, Jean Marie ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CRE RECOMBINASE; CYTIDINE; CYTIDINE DEAMINASE; IMMUNOGLOBULIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CHICKEN; CONTROLLED STUDY; DEAMINATION; E2A GENE; ENHANCER REGION; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE CONVERSION; GENE DISRUPTION; GENE INACTIVATION; IMMUNOGLOBULIN HYPERMUTATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION; TRANSCRIPTION INITIATION SITE;

EID: 33745309534     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.1.395     Document Type: Article

References (24)

1. Neuberger, M. S., R. S. Harris, J. Di Noia, and S. K. Petersen-Mahrt. 2003. Immunity through DNA deamination. Trends Biochem. Sci. 28: 305-312.
2. Peters, A., and U. Storb. 1996. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4: 57-65.
3. Gordon, M. S., C. M. Kanegai, J. R. Doerr, and R. Wall. 2003. Somatic hypermutation of the B cell receptor genes B29 (Igβ, CD79b) and mb1 (Igα, CD79a). Proc. Natl. Acad. Sci. USA 100: 4126-4131.
4. Betz, A. G., C. Milstein, A. Gonzalez-Fernandez, R. Pannell, T. Larson, and M. S. Neuberger. 1994. Elements regulating somatic hypermutation of an immunoglobulin κ gene: critical role for the intron enhancer/matrix attachment region. Cell 77: 239-248.
5. Storb, U., A. Peters, E. Klotz, N. Kim, H. M. Shen, J. Hackett, B. Rogerson, and T. E. Martin. 1998. cis-Acting sequences that affect somatic hypermutation of Ig genes. Immunol. Rev. 162: 153-160.
6. Michael, N., H. M. Shen, S. Longerich, N. Kim, A. Longacre, and U. Storb. 2003. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 1: 235-242.
7. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
8. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
9. Arakawa, H., J. Hauschild, and J. M. Buerstedde. 2002. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295: 1301-1306.
10. Harris, R. S., J. E. Sale, S. K. Petersen-Mahrt, and M. S. Neuberger. 2002. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12: 435-438.
11. Rada, C., G. T. Williams, H. Nilsen, D. E. Barnes, T. Lindahl, and M. S. Neuberger. 2002. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12: 1748-1755.
12. Yoshikawa, K., I. M. Okazaki, T. Eto, K. Kinoshita, M. Muramatsu, H. Nagaoka, and T. Honjo. 2002. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 14: 2033-2036.
13. Kotani, A., I. M. Okazaki, M. Muramatsu, K. Kinoshita, N. A. Begum, T. Nakajima, H. Saito, and T. Honjo. 2005. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc. Natl. Acad. Sci. USA 102: 4506-4511.
14. Kee, B. L., M. W. Quong andC. Murre. 2000. E2A proteins: essential regulators at multiple stages of B-cell development. Immunol. Rev. 175: 138-149.
15. Conlon, T. M., and K. B. Meyer. 2004. Cloning and functional characterisation of avian transcription factor E2A. BMC Immunol. 14: 5-11.
16. Arakawa, H., D. Lodygin, and J. M. Buerstedde. 2001. Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol. 1: 7.
17. Caldwell, R. B., A. M. Kierzek, H. Arakawa, Y. Bezzubov, J. Zaim, P. Fiedler, S. Kutter, A. Blagodatski, D. Kostovska, M. Koter, et al. 2005. Full-length cDNAs from chicken bursal lymphocytes to facilitate gene function analysis. Genome Biol. 6: R6.
18. Arakawa, H., H. Saribasak, and J. M. Buerstedde. 2004. Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate. PLoS Biol. 2: 967-974.
19. Saribasak, H., N. N. Saribasak, F. M. Ipek, J. W. Ellwart, H. Arakawa, and J. M. Buerstedde. 2006. Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations. J. Immunol. 176: 365-371.
20. Angerer, W. P. 2001. An explicit representation of the Luria-Delbrück distribution. J. Math. Biol. 42: 145-174.
21. Di Noia, J. M., and M. S. Neuberger. 2002. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419: 43-48.
22. Simpson, L. J., and J. E. Sale. 2003. REV1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J. 22: 1654-1664.
23. Ross, A. L., and J. E. Sale. 2006. The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40. Mol. Immunol. 43: 1587-1594.
24. Conlon, T., and K. Meyer. 2006. The chicken Ig light chain 3′-enhancer is essential for gene expression and regulates gene conversion via the transcription factor E2A. Eur. J. Immunol. 36: 139-148.